header logo image


Page 799«..1020..798799800801..810820..»

How worms revealed a key protein in insulin synthesis and diabetes – FierceBiotech

December 11th, 2019 10:46 am

By studying the nematode Caenorhabditis elegans, scientists from Vanderbilt University and the University of Michigan have identified a protein that's key for insulin synthesis, the understanding of which they say could lead to new approaches to prevent and treat Type 2 diabetes.

The protein, called TRAP-alpha, is widely shared across worms, flies and mammals, including humans. In a study published in the journal Science Advances, the team showed that TRAP-alpha is required for insulin production, corroborating previous knowledge that alterations in the TRAP-alpha gene are linked to the development of diabetes.

The researchers made the discovery while screening for genetic clues to the PI3K/Akt signaling pathway that may contribute to reduced insulin signaling. Irregularities in the PI3K/Akt pathway have been linked to many human diseases, including cancer, cardiovascular disease anddiabetes.

How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC

CROs are often at the forefront of adopting new technologies to make clinical trials more efficient. Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management.

The screens turned up TRAP-alpha. The protein is part of a complex known as translocon that helps moveor translocatenewly synthesized proteins into the endoplasmic reticulum (ER) of cells for further processing before theyre eventually secreted.

The researchers discovered that deletingthe C. elegans equivalent of TRAP-alpha affects the worms' insulin signaling pathway.

They went on to delete TRAP-alpha in insulin-making pancreatic beta cells of rats. Doing so led to a sharp decline in total insulin, the team found. Preproinsulin, the precursor molecule to insulin, was not properly transferred into the ER for final processing, so most of it was degraded.

TRAP-alpha was not on anyone's radar in terms of being required for insulin biogenesis, Patrick Hu, the studys senior author, said in a statement. Our work highlights the value of using a model organism likeC. elegansto do an unbiased genetic screen. It led us to a molecule that seems to be important in making insulin and that could very well shed light on the pathogenesis of diabetes, a common disease that affects about 10% of the U.S. population.

RELATED:Subtle chemical shift reverses prediabetes in Merck-partnered mouse trial

Given the prevalence of diabetes, several research groups are also working on new ways to tackle it. Scientists from the University of Utah, in collaboration with Merck Research Laboratories, recently prevented or reversed prediabetes in mice. They did it by shutting down an enzyme called DES1 to reduce the amount of fatty lipid ceramides, which is key in metabolic health.

A team at the University of Geneva treated Type 1 diabetes in mice byconverting non-insulin-producing alpha and gamma endocrine cells into beta cells with the help of two transcription factors, PDX1 and MafA.

Understanding TRAP-alpha could inspire new ideas to prevent or treat Type 2 diabetesand maybe even more diseases, Hu and colleagues argued.

In the current study, the researchers noticed TRAP-alpha plays a role in promoting ER homeostasis, or the balance between incoming proteins and ER the proteins that help fold them. Loss of TRAP-alpha may cause ER stress, which can lead to cell death, the team reported.

Preproinsulin is the first client protein for TRAP-alpha to deliver into the ER for processing, and the scientists hope to find more like it.

It's likely other secreted molecules besides insulin might be affected by TRAP-alpha deletion, Hu said in a statement. If we can understand the broader role that TRAP-alpha is playing in maintaining protein homeostasis, we might develop new ways to approach other diseases, too.

More:
How worms revealed a key protein in insulin synthesis and diabetes - FierceBiotech

Read More...

Harvey Weinstein’s diabetes and spine condition to blame for his appearance – Page Six

December 11th, 2019 10:46 am

Harvey Weinstein hobbled into Manhattan court Friday looking pallid and unsteady thanks to severe diabetes and a spine condition, sources told The Post.

The 67-year-old accused rapist and former powerhouse Hollywood producer who was in court for a new bail hearing has suffered from Type 2 diabetes, back issues and other health problems that have been in free-fall since his arrest, sources said.

Weinsteins health problems paved the way for him to be allowed to wear a modified monitoring device while hes out on bail awaiting trial on sex charges and the gadget was at the heart of Fridays hearing.

Weinstein who had a handler help prop him up as he entered the courtroom was originally outfitted with a regular ankle bracelet, but because of his health issues, bail bondsman Ira Judelson swapped it out for a two-part device. The new device includes a slimmer ankle bracelet with a separate signaling component. The original device is not prone to the same user error.

The one-piece device was problematic for his leg and medical issues, Weinsteins lawyer, Donna Rotunno, told the court of the original, much bulkier monitor.

But Assistant DA Joan Illuzzi-Orbon said Weinsteins ankle monitor was untraceable on at least 56 separate occasions, in violation of his bail conditions. Prosecutors said Weinstein repeatedly failed to keep within range as required.

Due to the violations and new bail reform laws taking effect next year, Weinsteins bail package has to be re-examined, with both sides making their arguments Friday. Justice James Burke is set to rule on the issue Wednesday.

Weinstein is currently free on $1 million cash bail. He faces up to life in prison on charges of predatory sexual assault, criminal sex act and rape in connection with three accusers.

Matthew McDermott

Read this article:
Harvey Weinstein's diabetes and spine condition to blame for his appearance - Page Six

Read More...

Diabetes treatment to cost less on cheaper version – Times of India

December 11th, 2019 10:46 am

MUMBAI: There is some good news for the over 72 million diabetics in India, with a cheaper version of a blockbuster drug hitting the market on December 10. The domestic pharmaceutical market is abuzz with news of over 15-20 companies launching generic versions of the widely-prescribed anti-diabetic drug Vildagliptin, with its price expected to crash by half.

The potential of more affordable diabetic care comes in the wake of Swiss major Novartis-owned Vildagliptin losing patent on Monday a development closely watched for months. Dozens of companies have readied plans to get a slice of the action in the growing Rs 14,000-crore diabetes therapy market, with the number of players expected to cross 50 soon.

With the drugs patent expiry, the price may drop to Rs 6 per tablet over the next few months, from the existing Rs 20-25 each. What makes the patent expiry significant for Indian pharma is that Vildagliptin is the first among the gliptins, a relatively new class of oral diabetes drugs, to get off the block, and also the first diabetes medicine whose end of patent life is being seen by industry. Vildagliptin is a part of a class of diabetes medications called dipeptidyl peptidase IV or DPP4 inhibitors.

The innovator brand Galvus (along with combination of Metformin) cornered around Rs 600 crore, a lions share of total Vildagliptin market of Rs 950 crore (moving annual total (MAT) November 2019). The company also has agreements with USV, Cipla and Abbott, with their brands Jalra, Vysov and Zomelis respectively available in 50mg Vildagliptin, and in combination with Metformin.

Days before the launch, the market started hotting up with Mumbai-based Eris Lifesciences acquiring Zomelis from Novartis for around Rs 100 crore, and USV reportedly being in talks to acquire Jalra. When contacted, a Novartis spokesperson said, When patents expire, high-quality generics help lower the overall cost of healthcare and improve access to medicines for societies around the world, in a circle of discovery, development, commercialisation and loss of market exclusivity. We will continue to serve people living with diabetes through the innovator molecule in India, Galvus.

Read the original post:
Diabetes treatment to cost less on cheaper version - Times of India

Read More...

Message to young women with diabetes: Marriage and children, you can have it all! – Times of India

December 11th, 2019 10:46 am

In the last 21 years, I have been working closely with young women who have type 1 or type 2 diabetes and many of them have voiced a persistent concern and fear: will they be able to lead a fulfilling life as wives and mothers. They seem to have received little or no reassurance from family and friends. Social discrimination, misconceptions and stigma are still creating psychological and emotional problems for these young women.Research shows that societal stigma, shaming or discrimination of people with diabetes has a negative impact on patient self-care and leads to poor treatment outcomes.[i] Women face much more of this than men. They are deemed unfit for marriage and motherhood. They face this stigma on all fronts: from their own family, extended relatives, colleagues at work and from prospective spouses and their families.I would like to clear some of these misconceptions and send out a message of hope and reassurance to these young women.Never assume, always ask the doctorLack of understanding is the source of this stigma, both in rural and urban India. Poor understanding of the disease at all levels - patients, families, prospective in-laws, co-workers - creates a web of fear about the disease, its risks and its impact on everyday living. So many families assume no one wants to wed their daughter, because she has a lifelong chronic condition. They also assume that the young woman will be unable to bear children, and if she does, the child will be at risk of developing diabetes at some point in life.

In light of this, it becomes the doctors responsibility to guide patients and their families, give them the information they need on general diabetes management and particularly on pre and post-natal diabetes care. Patients need to be told that while diabetes does increase the risk of certain complications, advancements in medicine and technology have made these well manageable today.

Do not hide your condition, and never neglect your medicationI have met several young women patients in the process of finding a marriage partner, struggling with the dilemma of whether to tell their prospective partners and families about their diabetes status. Many have reported that when they did open up about their condition soon after marriage, they were advised to seek alternative medical treatment by their husbands and in-laws and asked to give up insulin therapy! Hiding the fact that they have diabetes has also led to an erratic medication schedule leading to horrifying results. Many patients developed a condition called ketoacidosis (excess blood acids called ketones) and needed to be rushed to the emergency room.

One of my biggest concerns is that newly diagnosed patients sometimes keep their diabetes status a secret from even their immediate family and colleagues for fear of judgement. Some of my new patients admit to taking their insulin or checking their blood sugar only in the privacy of their washroom, and do not do so as often as recommended if they are in a public place.

My message to patients here is simple: no person and no circumstance must ever trump your own health. Neglecting to monitor your blood sugar or to take your medication as prescribed, can put you at high risk of many complications, some of which are life threatening. Patients on insulin therapy should ask their doctor to help pick an insulin type that suits their daily schedule and body requirements.

Read the original:
Message to young women with diabetes: Marriage and children, you can have it all! - Times of India

Read More...

She invented a product to help those with Type 1 diabetes, and she’s featured in a new book – East Idaho News

December 11th, 2019 10:46 am

Laurel Bloomfield of Rigby is a contributing author for a new book targeted to entrepreneurs. | Courtesy photos

RIGBY Laurel Bloomfield of Rigby is an entrepreneur, inventor, mother and wife, and she will soon add author to her list of accomplishments.

She is one of 71 authors who will be featured in Air Fryer Secrets. Its not a cookbook rather, its an anthology providing business-building tips and strategies. Each chapter was written by a different author and caters to a specific niche in the marketing and entrepreneurial space.

Everything you would need to start an online business today is covered in the book, Bloomfield tells EastIdahoNews.com.

Bloomfields contribution is a chapter about intellectual property and how a product developer can write their own patent. She co-created a product with Nicholle Peterson and Katie Larsen several years ago designed to help those with Type 1 diabetes who wear an insulin pump. Its a pocket thats placed in the lining of clothing to hide it from view and keep it safe from damage.

RELATED | Local moms design a trendy way to carry insulin pumps

If you send a 5-year-old kid to school with a $10,000 pump, and they try to use the bathroom, it could fall in the toilet. Other kids have cut the tubing thats hanging out of their shirt going from the pump to the infusion site. That can be a life-threatening situation, Bloomfield says.

Her pocket helps keep that device safely up against their body and holds all the tubing in place to avoid all risks of danger. The pocket also gives kids a way to hide their condition so they do not become a spectacle to people around them, she says.

I think thats important for kids dealing with Type 1 diabetes. Sometimes theyre expected to be the spokesperson for this huge disease just because they have this noticeable thing (on their body). The pocket allows them to just be kids, says Bloomfield.

Bloomfields pocket concept gained a lot of traction from some of the leading insulin pump manufacturers in the world. It was put on the market about three years ago once her fully-issued patent was approved. Today, its sold online and in stores under the name Pocket Innerware.

Boise resident Kevin Quinn, the lead author of Air Fryer Secrets, has worked with Bloomfield on numerous development projects. Hes a software developer and a partner at a CBD company, among other things. He invited her to share her expertise with readers for this book.

The inspiration for the book came from a series of live Facebook videos Quinn began posting about eight months ago.

I wanted to show folks what I could cook in the air fryer one Friday. It was funny. People tuned in and had some fun with it. Then it started to grow and people started to ask What are you cooking for Fryer Friday?' Quinn says.

The initial post was intended as a joke, but it quickly went viral and eventually became a weekly bit called Fryer Friday.

The videos have since become a Facebook engagement tool to help build an audience for many of his business projects. The title of the book is a play on words intended to convey its central message of putting yourself out there to build brand awareness.

You need to decide who your audience is that you want to sell to, and then find a unique way to sell to them, Quinn says. This book will give them so many ideas (on) how to do that.

Bloomfield and Quinn recently launched a business together called Launch Incubator, which helps entrepreneurs find an audience for their product.

Bloomfield says she is excited to be able to offer marketing strategies and other resources for current and prospective business owners.

Its kind of like a digital marketing Bible. Its something that, when I got into this space 18 months ago, I wish I wouldve known more about, Quinn says.

Air Fryer Secrets will be available to buy through Amazon on Dec. 19. Visit the website to learn more.

Continue reading here:
She invented a product to help those with Type 1 diabetes, and she's featured in a new book - East Idaho News

Read More...

Limited eating times could be a new way to fight obesity and diabetes – The Conversation US

December 11th, 2019 10:46 am

People with obesity, high blood sugar, high blood pressure or high cholesterol are often advised to eat less and move more, but our new research suggests there is now another simple tool to fight off these diseases: restricting your eating time to a daily 10-hour window.

Studies done in mice and fruit flies suggest that limiting when animals eat to a daily window of 10 hours can prevent, or even reverse, metabolic diseases that affect millions in the U.S.

We are scientists - a cell biologist and a cardiologist - and are exploring the effects of the timing of nutrition on health. Results from flies and mice led us and others to test the idea of time-restricted eating in healthy people. Studies lasting more than a year showed that TRE was safe among healthy individuals. Next, we tested time-restricted eating in patients with conditions known collectively as metabolic syndrome. We were curious to see if this approach, which had a profound impact on obese and diabetic lab rats, can help millions of patients who suffer from early signs of diabetes, high blood pressure and unhealthy blood cholesterol.

Its not easy to count calories or figure out how much fat, carbohydrates and protein are in every meal. Thats why using TRE provides a new strategy for fighting obesity and metabolic diseases that affect millions of people worldwide. Several studies had suggested that TRE is a lifestyle choice that healthy people can adopt and that can reduce their risk for future metabolic diseases.

However, TRE is rarely tested on people already diagnosed with metabolic diseases. Furthermore, the vast majority of patients with metabolic diseases are often on medication, and it was not clear whether it was safe for these patients to go through daily fasting of more than 12 hours as many experiments require or whether TRE will offer any benefits in addition to those from their medications.

In a unique collaboration between our basic science and clinical science laboratories, we tested whether restricting eating to a 10-hour window improved the health of people with metabolic syndrome who were also taking medications that lower blood pressure and cholesterol to manage their disease.

We recruited patients from UC San Diego clinics who met at least three out of five criteria for metabolic syndrome: obesity, high blood sugar, high blood pressure, high level of bad cholesterol and low level of good cholesterol. The patients used a research app called myCircadianClock, developed in our lab, to log every calorie they consumed for two weeks. This helped us to find patients who were more likely to spread their eating out over the span of 14 hours or more and might benefit from 10-hour TRE.

We monitored their physical activity and sleep using a watch worn on the wrist. As some patients with bad blood glucose control may experience low blood glucose at night, we also placed a continuous glucose monitor on their arm to measure blood glucose every few minutes for two weeks.

Nineteen patients qualified for the study. Most of them had already tried standard lifestyle interventions of reducing calories and doing more physical activity. As part of this study, the only change they had to follow was to self-select a window of 10 hours that best suited their work-family life to eat and drink all of their calories, say from 9 a.m. to 7 p.m. Drinking water and taking medications outside this window were allowed. For the next 12 weeks they used the myCircadianClock app, and for the last two weeks of the study they also had the continuous glucose monitor and activity monitor.

After 12 weeks, the volunteers returned to the clinic for a thorough medical examination and blood tests. We compared their final results with those from their initial visit. The results, which we published in Cell Metabolism, were pleasantly surprising. We found most of them lost a modest amount of body weight, particularly fat from their abdominal region. Those who had high blood glucose levels when fasting also reduced these blood sugar levels. Similarly, most patients further reduced their blood pressure and LDL cholesterol. All of these benefits happened without any change in physical activity.

Reducing the time window of eating also had several inadvertent benefits. On average, patients reduced their daily caloric intake by a modest 8%. However, statistical analyses did not find strong association between calorie reduction and health improvement. Similar benefits of TRE on blood pressure and blood glucose control were also found among healthy adults who did not change caloric intake.

Nearly two-thirds of patients also reported restful sleep at night and less hunger at bedtime similar to what was reported in other TRE studies on relatively healthier cohorts. While restricting all eating to just a six-hour window was hard for participants and caused several adverse effects, patients reported they could easily adapt to eating within a 10-hour span. Although it was not necessary after completion of the study, nearly 70% of our patients continued with the TRE for at least a year. As their health improved, many of them reported having reduced their medication or stopped some medication.

Despite the success of this study, time-restricted eating is not currently a standard recommendation from doctors to their patients who have metabolic syndrome. This study was a small feasibility study; more rigorous randomized control trials and multiple location trials are necessary next steps. Toward that goal, we have started a larger study on metabolic syndrome patients.

Although we did not see any of our patients go through dangerously low levels of glucose during overnight fasting, it is important that time-restricted eating be practiced under medical supervision. As TRE can improve metabolic regulation, it is also necessary that a physician pays close attention to the health of the patient and adjusts medications accordingly.

We are cautiously hopeful that time-restricted eating can be a simple, yet powerful approach to treating people with metabolic diseases.

[ Deep knowledge, daily. Sign up for The Conversations newsletter. ]

View post:
Limited eating times could be a new way to fight obesity and diabetes - The Conversation US

Read More...

Homepage Round-Up: Depressed Doctors Make More Medical Errors; The Lasting Effects of Gunshot Wounds; and More – DocWire News

December 11th, 2019 10:44 am

Here are the top stories covered byDocWire Newsthis week in the Homepage section. In this weeks edition of the round-up: physicians suffering with symptoms of depression make more medical errors, mining alcohol related Tweets is the best way to gather public health data; short-term exposure to air pollution increases hospital admissions and costs; and gunshot wound survivors have high rates of PTSD, unemployment, and substance abuse.

Physicians suffering from symptoms of depression are more likely to make medical errors, according to the findings of arecent studypublished inJAMA Network Open. By combining data from multiple studies, this systematic review and meta-analysis found that physician depressive symptoms were associated with increased risk for perceived medical errors and that the association between depressive symptoms and perceived errors was bidirectional, the authors wrote.

A new study published in theAmerican Journal of Preventative Medicinesuggests that mining peoples alcohol-related tweets and online searchers is a faster, and more efficient method than the tradition method of collecting rigorous public health data through large survey-based studies. Informal social media and search data may be really important for detecting and responding to things that we dont anticipate or that occur naturally, said the senior study author: Our results give confidence in our public health tools and in using novel data approaches to measure health behaviors and policy effects a real win.

Short-term exposure to fine particulate matter with diameter less than 2.5 m (PM2.5)is associated with increased rates of hospital admissions and health insurance costs, according to the findings of arecent studypublished inBMJ. New causes and previously identified causes of hospital admission associated with short term exposure to PM2.5were found, the researchers wrote. These associations remained even at a daily PM2.5concentration below the WHO 24-hour guideline. Substantial economic costs were linked to a small increase in short term PM2.5.

The lasting effects of gunshot wounds (GSWs) reach far beyond mortality and economic burden, and survivors incur higher instances of post-traumatic stress disorder (PTSD), unemployment, and substance abuse, according to thefindingsof a new study published byJAMA Surgery. The researchers wrote that: Survivors of GSWs may have negative outcomes for years after injury. These findings suggest that early identification and initiation of long-term longitudinal care is paramount.

Originally posted here:
Homepage Round-Up: Depressed Doctors Make More Medical Errors; The Lasting Effects of Gunshot Wounds; and More - DocWire News

Read More...

Helsinki’s Neosmart Health raises 1.2 million to expand its patented preventative healthcare system – Tech.eu

December 11th, 2019 10:44 am

Neosmart Health, the Finnish preventative healthcare startup, has closed a 1.2 million seed round to pursue its mission of keeping people healthy. The round was led by various investors from the Nordics, North America, and Africa, including Sami Laine, Martti Lepist, Kari Helin, Ahmed Eltigani, Niilo Pellonmaa, and Timo Mkel.Over 75% of chronic illnesses burden arise from preventable conditions and only with preventive healthcare, we can manage the costs and extend the healthy lifetime for all of us, said co-founder and CEO Marko Nurmela.The company combines technology, such as AI and wearables, with traditional medicine to design individualised health optimisation plans for patients.Our methodology is based on deep data analytics and what differentiates us from others is our holistic approach towards health. We look at health from multiple fronts, including comprehensive blood analysis, gut microbiome, food sensitivity, immunity profile, wearables data, genomics and everything else that is required for an individual, explained founder and Chief Medical Officer, Dr. Pertti Lhteenmki.In addition to data-driven tools, patients are paired with Neosmart-licensed doctors at Neosmarts brick-and-mortar clinics. Part of the companys short-term vision is to attract and license more doctors in the Neosmart system.Since starting its operations in 2018, the company has hired 19 employees, located in the Helsinki headquarters or the Dubai office. Both locations have afforded strategic partnerships: the retailer S-Group in Finland, and the Dubai Sports Council and Dubai government (though no further information has been disclosed on this point). So far Neosmart also two patents in the US and other markets.Commenting on the companys aspirations, Marko said: This is just the beginning and were already in discussions for our Series A round next, to accelerate the development of our deep data analytics platform and AI, and start offering our services in new markets Sweden, Estonia, Dubai and start the ground work on our expansion to the US, UK, India, China and Japan.

The rest is here:
Helsinki's Neosmart Health raises 1.2 million to expand its patented preventative healthcare system - Tech.eu

Read More...

Is it wrong to think of food as medicine? – The Irish Times

December 11th, 2019 10:44 am

We need our clinicians to buy in to the concept that thy food is thy medicine, and thy medicine is thy food. Instead of arguing over what Hippocrates meant by this, exactly or whether he even said it why not encourage his medical descendants to take up this mantle?

Arguably, most doctors are more equipped to write a prescription or make a referral than to discuss nutrition and lifestyle interventions. Without question, pharmaceuticals have their place, but so does food as medicine, and our brilliant doctors in whom we trust must take greater steps towards preventative care and lifestyle interventions that will address the growing burden of type 2 diabetes, obesity and malnutrition in this country.

An estimated 60 per cent of adults and one in four children in Ireland are either overweight or obese. The direct and indirect costs to the exchequer which are associated with obesity are estimated to exceed 1 billion per annum.

The Healthy Ireland Framework 2013-2025 states that the health and wellbeing of everyone living in Ireland . . . is the most valuable asset that we possess as a nation. The report goes further to say that health in Ireland will be unsustainable in the future due to lifestyle diseases and ageing populations. It makes a strong argument for greater emphasis on illness prevention.

Therefore, I ask our politicians, the HSE and the Department of Health: if our health and wellbeing is such a prized asset, why isnt more being done to protect it?

Both hospitals and the food service sector are considered key areas for public policy interventions in this regard. Yet many doctors have no nutrition training. In the US, this has resulted in changes to curriculums whereby culinary medicine is being incorporated into doctor training in Harvard and Tulane universities, and even in some US hospitals. Nutrition knowledge and cookery education, like prescribed exercise, should become another tool in a clinicians toolkit. Ironically, the one place that we go to to get help when chronically unwell is a hospital. Yet doctors working there are ill-equipped to intervene or even get involved in this critical area.

In the UK, 50 million has been spent on failed bids to improve hospital food. Reports suggest 17 separate government initiatives since 2000 have resulted in no discernible improvement in the quality of meals served to patients. Albert Roux, James Martin and Loyd Grossman have all tried. Prue Leith has now taken up the baton.

But remaking hospital menus isnt easy.

Hospitals have to operate on strict budgets and food supply is frequently outsourced to companies that specialise in high volumes of food at a low cost often resulting in packaged and processed foods. Research shows us that 30-40 per cent of hospitalised patients are considered to be at risk of malnutrition. However, hospitals are a place where nutritionism rules.

Nutritionism is a term coined by the Australian sociologist Gyorgy Scrinis, and popularised by food writer Michael Pollan. It means reducing the value of a food to specific nutrients it contains. Its a little like the food pyramid which forms the basis of diet recommendations in Ireland.

A cereal advertisement I viewed recently is a perfect illustration of how nutritionism works. It talks about superfoods (health halo, anyone?) and we KNOW superfoods are healthy, right? By eating these cereal products, we get more zinc, more fibre and folic acid than . . . what? Not eating these processed cereals?

So how do we get zinc, iron, vitamin C, B6, fibre and folic acid if we dont eat the cereal?

Well, for starters we could eat meat, shellfish, legumes, nuts, dairy and eggs and even some dark chocolate for the zinc and iron. But the ad implies that eating more chocolatey cereal will serve you better than half a cup of black beans. As Marion Nestle, professor of nutrition at NYU, points out, such ads are not saying whether the iron from the fortified cereal is going to be absorbed as well as from the black beans, or what additional benefits youll get from eating the black beans and how much sugar is in the cereal versus the black beans. (For the record, 78 per cent of the cereal will turn to glucose once you eat it).

What we eat is central to human health, enabling the cells in our bodies to perform their functions via the nutrients, vitamins and energy consumed, but food also goes beyond calories and macronutrients. Anthropologists often declare You are what you eat, and certainly, by examining a persons diet, much can be gleaned about their background, financial status, religious beliefs and education level.

Since the 1970s, nutrition and public health experts have translated reductive principles Eat less fat! Eat less salt! Avoid processed foods! into dietary guidelines for the general public, telling us what to eat more of (fibre, vitamins, calcium, iron, Omega 3s, for example) and to avoid foods considered bad for health, such as saturated fats and refined foods high in sugar, salt and fat. Arguably, this abstract dietary advice is an oversimplification of something much more nuanced and complex. There are so many reasons as to why we eat the food that we do: for pleasure, convenience, and the cost of food, or due to food knowledge and our culture. Therefore, thinking about food in terms of calories-in and calories-out is reductive a mechanical approach [that] plays right into the hands of the food industry, as food writer Joanna Blythman says in her book What to Eat.

Food in hospitals is a budgetary nuisance. Improving the quality of hospital food service is complicated it has to deal with procurement, production, distribution/service, and safety/sanitation all of which are interrelated. Therefore, quality improvement strategies should be developed from a holistic point of view with engineering expertise: food service professionals in hospitals need to continuously research, plan and manage production processes to improve quality of products and efficiency of processes.

More chefs must be trained in culinary nutrition (thankfully happening out in IT Tallaght) and empowered as valued team members in hospital food service quality management who can communicate with patients.

If we could radically improve the food environment within hospitals, what impact would that have on both staff and patients?

Hospital food is often hardly recognisable as nourishing food, but rather as a source of safe calories. Food safety dominates our food production and is prioritised at all costs often at the expense of pleasure, culture and consumption. In addition, patients face a myriad of problems: inappropriate eating positions, food left out of reach, sounds, smells and cold temperatures that negatively affect food intake. Research shows that energy intake is improved among patients eating at a table rather than in bed ideally patients should eat communally unless they are completely bed-ridden, which would inevitably help with access, palatability and food waste. All of these principles should form part of a culinary medicine philosophy.

We should take the ounce of prevention approach. I think we can all agree that the rising cost of healthcare is unsustainable and that the economic burden of diet-related noncommunicable health risks and diseases is growing. Yet, while there is an obvious lack of healthy food procurement and promotion policies in institutions, worksites, schools and Government, it seems blindingly obvious to many of us that prevention is better than cure. For manypatients, nutritious food is medicine.

But what about detractors who say food is not medicine? That it doesnt matter if you get the iron and folate from cereals or whole foods whats important is just to get the nutrients. And this is where the arguments start to fall down: we know that iron is a mineral that serves several important functions such as carrying oxygen throughout your body and making red blood cells. However, although synthetic nutrients are almost chemically identical to those found in whole foods, the production process is very different to the ones found naturally in plants and animals. So despite the similar structures, your body may react differently to synthetic nutrients, especially when it comes to absorption.

When you eat whole foods, youre not consuming single synthetic nutrients, but rather a whole range of vitamins, minerals and enzymes that work synergistically to improve absorption: synthetic nutrients are unlikely to be used by the body in the same way. Take vitamin E, for example: studies show that natural vitamin E is absorbed twice as efficiently as synthetic vitamin E.

If clinicians better understood food and its importance to health and wellbeing, and made that understanding available to patients, families and healthcare systems for high-impact, low-cost, high-value care, then what effect would that have on the health of our nation?

And before you think I am suggesting that chewing parsley could replace a surgery, consider the following: is it wrong to think of food as medicine? Does it do a disservice to both food and medicine? Possibly because in reality, food is so much more than medicine: its social, its cultural and its a huge part of our lives. It is not just fuel and it is much more than nutrients but overemphasising the immediate impact of eating a superfood whilst ignoring long-term eating habits misses the mark. Eating junk food occasionally is very different to the impact on health when repeated regularly and combined with other unhealthy lifestyle habits (lack of sleep, insufficient exercise, smoking, drinking, stress).

Food is a significant human exposure and those of us fortunate enough to have food to eat every day can use it to impact our general health and wellness, including the prevention (or promotion) of chronic illness, and the management of virtually all diseases.

Food can definitely be medicine.

Too frequently though, the power of healthful eating is underrecognised or underapplied. Guidance related to food is not often part of a physicians armamentarium. This needs to change.

We need food education for our children and the best food environments for our hospitals.

Excerpt from:
Is it wrong to think of food as medicine? - The Irish Times

Read More...

Being Queer in the Jungle: The Unique Challenges of LGBTQ Scientists Working in the Field – The Good Men Project

December 11th, 2019 10:44 am

The Stonewall Riots occurred on June 28, 1969. It was this summer evening that sparked the Gay Rights Movement. Now, forty-eight years later, the world celebrates Pride Month every June to celebrate, honor, support, and fight for the lesbian, gay, bisexual, transgender and queer (LGBTQ) community.

The queer community is resilient. No matter what obstacles they encounter, their battle to live, pursue their passions, and contribute to society endures. For many queer people that passion is science. Queer scientists such as Alan Turing who was crucial in ending World War II, and Sara Josephine Baker who made unprecedented breakthroughs in child hygiene and preventative medicine.

Stonewall Inn, site of the 1969 Stonewall riots, New York City, USA

This blog post is meant to bring attention to queer scientists that are working in the field. Field research encompasses any type of scientific research that involves collecting data in non-laboratory locations. Several scientific areas involve fieldwork such as zoology, paleontology, and botany. The field is a fun and exciting place to perform science, however, for those who identify as queer1, working in the field can present challenges that may not be known to cis-gendered1or straight scientists.

The biggest decision for all LGBTQ individuals is whether to disclose their sexuality or gender identity. The decision to be out of the closet is an incredibly complex one in which all queer individuals have to evaluate the benefits versus costs. In general, staying in the closet and not disclosing ones sexuality or gender identity can be incredibly caustic, but there are many situations where staying in the closet is potentially safer than being out.

The risks for being out in the field are very location dependent. Dr. Siobhn Cooke from Johns Hopkins School of Medicine currently does work in theDominican Republic and Colombia. She feels comfortable being out and talking about her wife while in the Dominican Republic and Columbia. However, when she did field work in Tanzania she did not come out because she thought it would be unsafe. African and Middle Eastern countries can be particularly dangerous for queer scientists. Homosexuality is punishable by death in Sudan, northern Nigeria, Somalia, and Saudi Arabia, and is illegal in a slew of other countries including Ethiopia, India, Tanzania and Uganda. These types of legal restrictions obviously make it unsafe for a queer scientist to be out.

Global Laws Against Homosexuality

Even if being LGBTQ is not illegal, local views and customs can make it unsafe or difficult for queer scientists to be out. Close relationships with locals are required for scientists to obtain permission to perform their research in a specific location or to garner an opportunity to employ locals to aid in data collection. Local stigma against queer people and the discovery that a queer scientist is in a research group can result in locals refusal to help the scientists.

Local stigma against queer people and the discovery that a queer scientist is in a research group can result in locals refusal to help the scientists.

Lewis Bartlett, a graduate student who studies bees in the United States South, has experienced these types of challenges. His research includes collaborations with rural beekeepers many of whom hold conservative views on LGBTQ individuals: Parts of the fieldwork often involve extended social situations with collaborators, local practitioners etc. In these informal settings with food, drink, and an expectation to be charming and sociable it is absolutely a worry that you may say something which jeopardizes a rapport with a collaborator. Much of this kind of research working with small hold beekeepers is done on a very informal basis and requires maintaining strong personal connections with these people. It is absolutely distracting to have to police what directions conversations go in.

Dr. Christopher Schmitt of Boston University exploresmechanistic and adaptive aspects of developmental variation. While doing fieldwork in South Africa, it was relatively safe for Dr. Schmitt to be out. However, the potential for being out of the closet did not necessarily mean it was the best idea in terms of successfully carrying out his science. There was one experience where two of his local field workers were using homophobic epithets. Dr. Schmitt knew that it would be risky to express his disapproval or discomfort. Speaking up could have led the field workers to suspect he was gay thereby putting a strain on the working relationship and potentially impeding his research. Luckily in this situation, one of Dr. Schmitts colleagues to whom he was out did speak up to express their discomfort with how the field workers were talking.

Knowing that there are situations where it would be safer for queer scientists to stay in the closet while working in the field, a discussion on the deleterious consequences of staying in the closet is critical. Dr. John Pachankis from the Yale School of Public Health studies the psychological implications of staying in the closet. Through his research he has come up with acognitive-affective-behavioral model of the consequences of staying in the closet. In this model Dr. Pachankis discusses the intersection between cognitive energy, affect, and behavior and its relationship to queer individuals remaining in the closet. Cognitive energy encompasses the amount of mental energy spent on psychological processes such as attention, reasoning, and decision making. Affect, meanwhile, describes emotional states such as joy, guilt, and depression.

In Dr. Pachankis description of his cognitive-affective-behavioral model, he explains how closeted individuals spend a significant amount of cognitive energy engaging in preoccupation and vigilance to make sure that others do not suspect they are queer. These cognitive activities of preoccupation and vigilance can result in affective responses of guilt, shame, demoralization and depression. These affective states, then have behavioral repercussions including avoiding social situations, weakening of close relationships, and engaging in risky behaviors such as unprotected sex and drug abuse.

While I never went back in the closet (something Im not sure I would know how to do anymore) it did undermine how authentically I felt I bonded with collaborators and colleagues. Dr. Schmitt

Staying in the closet, therefore, puts unnecessary cognitive demands for a queer person in the field where their main goal is to be a good scientist and collect data. When Dr. Schmitt was doing research in Gambia he ended up leaving a month early. A large part of this was due to the strong anti-gay feelings in the country where the president of Gambia was putting stings on gay people and making comments about slitting the throats of gay people.

When going to field sites in conservative areas of the American South, Lewis Bartlett said Being unaccustomed to editing how I present makes consciously considering it always a shock (this fieldwork is an annual event) modifying how I dress or act in order to not cause unnecessary problems will always feel upsetting. While I never went back in the closet (something Im not sure I would know how to do anymore) it did undermine how authentically I felt I bonded with collaborators and colleagues.

During an 18 month stint in Ecuador Dr. Schmitt described his experience of staying in closet. I wasnt ashamed of being gay, per se, but the same triggers that caused those feelings were there: having to hide, having to self-censor, playing the pronoun game, thinking twice before every statement, guarding your vocal inflections and hand gestures, choosing the correct interests to allay suspicions, making noncommittal comments about women when the other men ask for/expect them, getting crushes on men that you cant think too much about or reveal or talk to anyone about or act on because it would cause problems its all there again, and its all very hard to shake those feelings, even after years of living authentically and having grown into confidence as a gay adult.

Being transgendered in almost anywhere in the world is incredibly difficult, and this is of course true for transgender scientists working in the field, which presents its own unique challenges. Situations can be tricky for transgender scientists depending on where they are in their transitioning process. One challenge is documentation and paperwork. It can obviously be very problematic if the gender identification on all documentation is not the same. However, there can be even trickier situations.

One transgender scientist who had already been at a field site in East Africa prior to their physical transition knew that they were going to return to the field site. They made the very difficult decision of postponing their transition process. I consider my decision to delay my physical transition in order to conduct fieldwork an incredible sacrifice. I would have to delay the start of my life for another year. This postponement, however, was not sustainable, and they decided to start on a low dose of hormone replacement therapy. Although this decision was positive it was not without its challenges. For me, this decision was life-saving and I am finally getting better and am able to enjoy my research as I did before. But its not an ideal situation. As I am becoming my authentic self, I have to carefully monitor how others are perceiving me. Has my voice dropped too much? Is my facial structure noticeable different?

Margaret Mead was an anthropologist who studied indigenous people of the South Pacific and Southeast Asia. She had a romantic relationship with fellow anthropologist Rhoda Metraux and they lived together from 1955 till Meads death in 1978.

Discussing safety in relation to scientific research is standard. When going into the field, scientists are given a heads up on safety issues related to diseases and wildlife. They get vaccines, take anti-malarials, and take precautions on what water to drink. The amount of effort principle investigators put into preparing their students and field workers can vary. For some it is limited to basic preparation of what is expected of them in the field while others will determine if their students and field workers will be able to handle the psychological stressors of being in the field.

It could be beneficial for everyone if there was a standardized method to prepare individuals going into the field. In addition to principle investigators addressing disease risks and physical dangers, it would be valuable to talk about other potential safety issues such as cultural views related to queer people or women since dangers and safety issues are greater for these populations. By having these discussions standardized, it would mean that this information would be disseminated to scientists of all genders and sexualities. A standardized script would mean that principle investigator wouldnt have to be worried about making assumptions of whether a prospective student or research assistant were queer. Furthermore, it is important for men, cis-gendered, and straight scientists to know the kinds of risks that their female and queer colleagues may encounter.

For Dr. Cooke who is in her first year being a principle investigator at an institution with graduate students, she plans on having these conversations since carefully considered conversations about identity have generally not been on the table. Furthermore, being out is especially important for Dr. Cooke so that students know it is possible to be a queer woman scientist.

1Terminology:Queer:an accepted umbrella term to describe individuals who are neither cis-gendered nor straight Cis-gendered: individuals whose gender identity matches with their biological sex

Disclaimer: All interviewees provided permission to use their names and quotes.

This post was previously published on SpringerOpenBlog and is republished here under a Commercial Commons license.

Have you read the original anthology that was the catalyst for The Good Men Project? Buy here: The Good Men Project: Real Stories from the Front Lines of Modern Manhood

All Premium Members get to view The Good Men Project with NO ADS.

Need more info? A complete list of benefits is here.

Photo credit: Flickr

Read more:
Being Queer in the Jungle: The Unique Challenges of LGBTQ Scientists Working in the Field - The Good Men Project

Read More...

How Instagram Changed Food Forever in the 2010s – Robb Report

December 11th, 2019 10:44 am

Against my better judgement, I tapped the button to start the video. Immediately from out of frame a beef tenderloin comes flying, slamming down onto a large, filthy grill. Then, as the camera phone pans left, our hero is revealed. Its Salt Bae. And hes got a knife.

What happens next should be against the laws of God and man alike. The internet-famous butcher and chef Nusret Gke butterflies a perfectly good slab of meat, manhandles it some more and fills it with slices of cheap cheddar and asparagus. The video cuts to him planting mini-flags in his beef roulade, slicing it and then inexplicably squeezing the life out of it for the camera, looking quite pleased with himself the whole time. It ends with his trademark salt sprinkle cascading sodium down his forearm onto Frankensteins monster. To date, the video has been watched 8.2 million times since it posted in January 2018. And in the two intervening years, his follower count has nearly doubled to 24 million, despite the fact that, by most accounts, his restaurants are as bad as his cheesy asparagus beef roll looks.

Meanwhile, a few days after Salt Bae posted that video, Daniel Riesenberger, a.k.a.@danthebaker, uploaded his own clip. Off a tiny road outside of downtown Columbus, Ohio, in a black corrugated metal building that also houses the Sbarro Culinary Innovation Center, Riesenberger bakes bread. On Instagram we can follow the journey. His video was nothing flashy, just Riesenberger excited that he had a little mill now in his production kitchen where he could grind his own rye fresh for his breads. That video is flanked by other posts showing dough proofing, videos of him shaping loaves, shots of crumb (holes in a loaf) and pastry experiments hes working on. The chronicling of his work has brought Dan the Baker more than 40,000 followers. And it led me to visit his storefront earlier this year.

In the past, Riesenberger may have toiled in obscurity and anonymity. And I, a person living in Los Angeles, probably would have never heard of him. But just how Instagram introduced me to Salt Bae, the platform also led me to discover Dan the Baker. To my delight, when I sought him out, I found Riesenberger wasnt just showing off pretty pictures. His bakes were the genuine article. The texture and crumb of his oat porridge bread were some of the best Id had and the laminated dough in his croissants and cruffins rivaled the quality of big-city patisseries. Social media had not steered me wrong.

The Salt Bae-Dan the Baker dichotomy exemplifies the food worlds love-hate affair with Instagram in its first decade of existence. There was a kind of Newtons Law to the platform, where every action appeared to have an equal and opposite reactioneach positive effect seemed to carry an annoying inverse. Yet, no matter how restaurants or diners feel about it, Instagram has become a necessity that has reshaped how we eat, how chefs run their business and how we decide where to dine.

Instagram has let us indulge our most superficial tendencies, allowing whole empires to be built on the dumbest possible things. This decade a class of food emerged with the express purpose of getting us to pull out our phones and take a picture. Theres plenty of excitement about extremely superficial stuff that makes no sense to me, says Christian Puglisi of Relae in Copenhagen. But we need to live in an Instagrammable world for anybody to care, so unfortunately that appeals to doing some things that just look good on camera but do not really make a lot of sense if you think it through.

The camera-friendly ploys worked. People lined up around blocks for Cronuts, rainbow bagels, unicorn Frappuccinos, ramen burgers and, of course, Black Tap CrazyShakes.

Black Tap, the New York burger joint, rose to fame with a made-for-Instagram concoction that featured whole other desserts perched atop a shake. Accessing the frosty treat required digging through slices of cheesecake or perhaps a Choco Taco. Its like the restaurant version of the horror film The Ring, where anyone who watches the haunted tape dies. Except every person who sees a photo of a Black Tap shake gets type 2 diabetes. And if you bought it just so you could post it to Instagram and throw it away before eating, it didnt matter to them. The bank deposited the money either way.

And yet, not everyone was so cynical with how they used Instagram. A person or restaurants posts could give the public a glimpse into the creative process, and bring to attention people who wouldnt have otherwise received itlike Dan the Baker. Or like a young chef in Australia who has become known around the world because of his social media use.

From his little restaurant in Sydney, Josh Niland got creative with seafood. Through his posts he showed off butchery skills that had greats from Dan Barber to Grant Achatz requesting an audience when he finally came stateside this year. And his work came in service of something noblea more eco-conscious way of preparing fish that cuts down on food waste. Gaining Instagram followers showed me Oh, wow, people like this, Niland says. People message me to ask what to do with the fish theyve got, and I love the interaction. It helps me be in front of more people to talk about what Im doing. It puts my work to good use.

Chef Magnus Nilsson likes to tell a story thats not directly about dining, but speaks to what he sees at restaurants now. He recently found himself at a small party where John Legend just happened to sit down at the piano and play three songs for the gathered revelers. I sat very very close because although Im not a John Legend fan, this was a beautiful momenthow often do you get to hear an artist of that caliber playing piano and singing a few meters away? Nilsson says. And I turned around and looking back it was a wall of cell phones. Everyone was experiencing the moment through their phones. None of them were having the experienceI dont think that they were even listening. It was just sad.

Its not that different at restaurants this decade. Diners have turned into food paparazzi, swarming dishes with cameras the moment they land on the table. I think theres a really positive aspect to Instagram, but its also a little annoying to see people take pictures of their food for 20 minutes before they even touch it, says Gio Osso of Virtu in Scottsdale, Ariz. Its getting cold, what are you doing? Or for a dessert course you want to say, Your ice cream is melting, you dont need 15 pictures of it. That constant urge to document the meal also means theyre disconnected from the people right in front of themdiners are mediating the restaurant experience through an LED screen.

I think the phone has decreased the interaction of human beings, says Matthew Accarrino of SPQR in San Francisco. That sentiment may not just be alarmism. A 2017 study that appeared in the American Journal of Preventative Medicine, showed a significant association between social media use and increased depression, as people who spent more time on it reported increased feelings of social isolation. Social media may show you the whole world, but it may also make you feel alienated from it, as you see all these other people living their best lives.

And yet, it does have the power to connect communities of people who love food as well as bring diners closer to chefs and restaurateurs than in the past, like how I found Dan the Baker. It has been great for us, because another level of interaction with people who want to talk to you, says Jessica Koslow of Sqirl in Los Angeles.

It can help you get your message across to people, says Michael Tusk of Quince in San Francisco. And it doesnt have to just be pictures of food, you can use it for positive change by connecting for education purposes or showing people whats going on in your community.

That ambivalence is baked in to social media for Nilsson. Being part of this world is enables me to actually do something with my creative expression, he says. I mean, people wouldnt be coming to Fviken if it wasnt for a certain amount of interest in my person and a certain amount of hype, so its very complex.

Back when Matthew Accarrino was coming up as a young cook in New York in the pre-social media era, it was harder to know what food looked like inside the citys best restaurants. If he wanted to see Le Bernardin dishes, he might as well just go press his face up against the glass to see what the people were eating inside. But now I can type Le Bernardin into Instagram and see anything anyones ever taken a picture of, he says. The information is there, and it speeds the flow of that information to anyone.

The way starving chefs used to find out about the heights of fine dining was by waiting for cookbooks to be published. I came from a town of 3000 people. I thought you had to be from France to be a chef. I didnt know that was anything that I could ever even aspire to be, says Josh Habiger of Bastion in Nashville. My first job was in a diner. I remember seeing the Charlie Trotter cookbook and being like Whoa, this is food? This is more like art.'

Now chefs dont have to wait for a long publishing cycle to see the coolest new thing. We get ideas all the time from Instagram all the time. Probably every single day one of the cooks will show us something on Instagram to say, Look what these guys are doing,' says Alexander Hong of Sorrel in San Francisco. We get to see different flavor combinations or techniques, its a great great tool.

And yet, theres a downside. Scrolling through Instagram can reveal a lot of conformity because people are able to see and then quickly mimic the leaders like Ren Redzepi. I think theres a unifying thread through modern cuisine and I dont know if its a good thing or a bad thing. But food being produced in Copenhagen shouldnt look like food in Los Angeles, San Francisco or Tokyo, says Michael Cimarusti of Providence in Los Angeles. There should definitely be differences there, but I think thats part of the modern world that we live in, where everything is accessible within seconds from all the way around the world due to social media. I think it occurs at the detriment of your own creativity.

But even if theres some level of conformity, thats not necessarily a bad thing. Just this fall, persimmons hanging from strings inside restaurants flooded certain corners of Instagram. Chefs were drying the fruit to make the traditional Japanese delicacy hoshigaki. Id see pictures of Josh Skenes or Inua in Japan posting pictures and Im like, Thats so cool,' says Andy Doubrava of Rustic Canyon in Santa Monica, Calif. Hes not exactly sure what hell do with them, but Instagram allowed this Michelin-starred chef to find inspiration, guidance and the confidence to try something he hadnt before. And when its done right, the delicious results are passed along to us the diners. Its the best we can hope for from Instagram.

See the rest here:
How Instagram Changed Food Forever in the 2010s - Robb Report

Read More...

Scabies At ICE Facility In Aurora: Officials Trying To Contain Infestation Of Mites – CBS Denver

December 11th, 2019 10:44 am

AURORA, Colo. (CBS4) Crews at the U.S. Immigration and Customs Enforcementfacility in Aurora are trying to keep scabies from spreading. Its a highly contagious infestation of mites that burrow into the skin. The people living in one dorm are being kept away from everyone else.

A spokeswoman says these cases typically involve someone who is already infected when they arrive at the southern border. Scabies is treated with a topical medicine.

ICE officials released the following statement Monday:

With the recent influx of migrants entering from the U.S. southern border, U.S. Immigration and Customs Enforcement (ICE) has confirmed six cases of scabies at our Aurora Contract Detention Facility (ACDF). On-site medical personnel are credited with reducing the risk of further spreading the disease by quickly cohorting the six infected detainees along with 19 others who were also exposed to the disease.

Each ICE detainee receives a medical examination upon arrival at the facility to check for potential signs of illness.However, ICE has no way of knowing what diseases or viruses a person may have been exposed before they enter the facility.

A topical ointment will be administered to ICE detainees once the ointment is received at ACDF, which is anticipated to be Dec. 10. Once the treatment is administered, detainees will be removed from cohort. ICE and the on-site medical professionals employed by GEO took the necessary steps to quickly isolate the exposed detainees, provide proper medical care and prevent further spread of the disease. Preventative steps included early recognition and following the guidelines established by the CDC and the ICE Health Services Corps (IHSC).

Continue reading here:
Scabies At ICE Facility In Aurora: Officials Trying To Contain Infestation Of Mites - CBS Denver

Read More...

I belong here: Advocate works to raise profile of black women with breast cancer – San Antonio Express-News

December 11th, 2019 10:44 am

The first time Maimah Karmo attended the San Antonio Breast Cancer Symposium, she felt out of place.

Karmo was in awe of the breadth of expertise at the conference, which is one of the largest annual gatherings of breast cancer specialists and researchers. A breast cancer survivor herself, Karmo had been involved in advocacy for years as the founder and CEO of the Tigerlily Foundation, a national nonprofit that educates and supports younger women who are affected by the disease.

As she walked around the Henry B. Gonzlez Convention Center then, Karmo recognized the importance of the work around her, but she was struck by the dearth of black women like her. She knew that as a group, black women were about 40 percent more likely to die from breast cancer than white women, so their absence was notable.

On ExpressNews.com: Research finds outcome disparities for black women with early-stage breast cancer

I felt so overwhelmed. Im like, theyre doctors, theyre researchers, theyre smarter than me. I didnt want to talk. I didnt know what to say, Karmo said of her first experience with the symposium. And then over time I go, Wait, I belong here. Im the one theyre talking about. So why arent there more of me at the table?

After last years conference, Karmo decided shed had enough. It was time, she believed, for the voices of black women living with breast cancer to get higher priority. On Tuesday morning, as the international conference got underway at the convention center, Karmo was instead at a dining room at the Menger Hotel, where she was leading a series of presentations and panels on the disparities in treatment and outcomes for black women with metastatic, or late-stage, breast cancer.

Throughout the morning, a series of speakers highlighted the numerous barriers that black women face when it comes to breast cancer, from accessing preventative health care to participating in clinical trials. Those problems, Karmo told those gathered, have been exacerbated by the black communitys distrust of a medical system that has historically mistreated and experimented on black people.

On ExpressNews.com: The number of deaths from prostate cancer was not increased by finasteride, study led by San Antonio researcher finds

Shawn Johnson, a student at Harvard Medical School, drove that point home when he recounted the history of the Tuskegee study, during which researchers withheld treatment for black men with syphilis so they could observe the sexually transmitted diseases effect on the body. The participants, he said, were not told about the purpose of the research and were not offered penicillin, which became the standard treatment for the illness about 15 years into the four-decade-long study.

We cant forget how we got here, he said.

Johnson also noted the way in which black women have been excluded from breast cancer clinical trials, which play a key role in advancing treatment of the disease and provide those who have already been diagnosed with earlier access to promising treatments. He called up information from one clinical trial that included about 4,000 people, only 20 of whom were black women.

Its important that we begin to speak up, said Nikia Hammonds-Blakely, an advocate and public speaker who was first diagnosed with breast cancer at age 16. Because it really informs the work.

Hammonds-Blakely said some women may also be unable to access preventative care like mammograms due to economic barriers, such as a lack of access to transportation.

Dr. Tatiana Prowell, an associate professor of oncology with Johns Hopkins Medicine who also serves as a medical officer and breast cancer scientific liaison to the Food and Drug Administration, said its time to rethink the way clinical trials are conducted. Studies would be more inclusive if the medical system took steps to reconsider criteria for eligibility and decentralized some of the ongoing testing and scans to take unnecessary burdens off patients.

Top hits: Get San Antonio Express-News stories sent directly to your inbox

Dr. Lori Wilson, a cancer surgeon affiliated with Howard University, said she has been diagnosed with three different types of breast cancer since 2013. She learned her cancer had become metastatic earlier this year.

The thing to know is that we need to make sure that we understand that theres still gaps in survival, that even though weve done so much, we have come so far, there is a difference between breast cancer in white women and black women and that we need more research to know why, Wilson said.

Lauren Caruba covers health care and medicine in the San Antonio and Bexar County area. Read her on our free site, mySA.com, and on our subscriber site, ExpressNews.com. | lcaruba@express-news.net | Twitter: @LaurenCaruba

Here is the original post:
I belong here: Advocate works to raise profile of black women with breast cancer - San Antonio Express-News

Read More...

Amazon and Apple will be our doctors in the future, says tech guru Peter Diamandis – Fast Company

December 11th, 2019 10:44 am

Healthcare is the biggest business in the world, and it is phenomenally broken, says Peter Diamandis, cofounder of the X-Prize, Singularity University, and Health Longevity Inc. So, do I think Apple and Google and Amazon can do a better job? A thousandfold.

In his upcoming book,The Future Is Faster Than You Think, which will hit bookshelves in late January 2020, Diamandis makes the case for why he believes big tech companies are going to be running healthcare by 2030. In December, he came to Fast Companys offices to make the case for why Big Tech is the doctor of the future.

Were going to see Apple and Amazon and Google and all the data-driven companies that are in our homes right now become our healthcare providers, he says, referring to smart speakers such as Googles Assistant, Amazons Alexa, and Apples HomePod. While many of these home voice assistants started with simple tasks like restocking home pantries and surfacing cooking tutorials, theyre already starting to move into the business of managing family well-being.

Amazon has put significant effort into making Alexa a health resource. In the United Kingdom, it has partnered with the National Health Service to answer basic health questions such as What are the symptoms for shingles? or What do you do if you have a cold? It has also made Alexa compliant with U.S. HIPAA laws and signed partnerships with major healthcare insurers and providers so patients can access or remit health information through the device. To date, there are nearly 2,000 health wellness skills on its platform.

Healthcare is the biggest business in the world, and it is phenomenally broken.

Similarly, the Google Assistant uses search to serve up information about medications, symptoms, and diseases, as well as physicians and medical services. Both the Google Home and the Echo have a Mayo Clinic-developed skill called First Aid that helps people navigate minor injuries. Meanwhile, Apples HealthKit takes a slightly different approach to tackling personal health. The kit connects to Apples own products such as the HomePod, iPhone, and Apple Watch as well as a bevy of devices from other companies, such as scales and blood pressure cuffs. The HealthKit can also tap into electronic medical records and other apps connected to hospitals and doctors. Essentially, it becomes a single repository for all your precious health data.

[Photo: courtesy of Apple]Diamandis believes the involvement of home health devices has the potential to lower costs by shifting care away from hospitals, where expenses can be much higher. This is the general idea behind telemedicine, but Diamandis thinks that big consumer tech companies will play a big role in driving that vision. He also thinks that these companies, which have mastered using personal data to anticipate user behavior, can use personal health data to make predictions about a persons long-term health prospects and advise them accordingly.

Diamandis posits that the more information is available about youyour genetic makeup, your health history, what you ate for breakfast, the bacteria in your bowel movement, how you slept last night, what kind of sound youre exposed to every daythe better artificial intelligence will be at spotting your potential for illness and suggesting care before the problem becomes intractable. This approach might shift the medical establishment from a structure that treats disease once its wreaking havoc in your body to one that prevents the disease from striking in the first place. It is literally hundreds if not thousands of times cheaper to do that, he says.

It is literally hundreds if not thousands of times cheaper to do that.

It is this cost savings that he believes will allow for new models of healthcare. Diamandis predicts Apple and Amazon will come up with a service where a person pays a company to keep them healthy, rather than to cover the cost of illness, based on their health history and daily activities. And big tech could not only influence a person to make healthier decisions, it could force them. Amy Webb, professor of strategic foresight at New York Universitys Stern School of Business, has spoken at length about the possibility that in a futuristic situation when Amazon, Google, and Apple run your entire house as well as your healthcare, smart refrigerators could cut you off from snacking between meals and smart garages could keep you from accessing your car in favor of walking to work.

Diamandis believes that by knowing a persons predisposition for disease, these companies could help them live a healthy lifestyle with their particular abnormalities in mind. Can you prevent those things, so we dont have these extraordinary costs? he asks. It will be these services, he believes, that will lead healthy people to dispense with traditional health insurance, leading to its ultimate demise.

Diamandiss vision of healthcare in 2030 raises a lot of questions. First and foremost, do these big tech companies want to become healthcare providers? So far, the only one that has really signaled its desire to become your doctor is Amazon. In addition to its work with Alexa, the company has launched its own health clinic for employees and is working on a secretive health project with JP Morgan and Berkshire Hathaway called Haven. But Apple and Google, at least so far, seem content to integrate their technology with traditional health providers as a way of advancing their practices. Meanwhile, the insurance industry is more likely to adapt to a preventative health model than it is to collapse completely. A survey from last year shows insurers are increasingly signing contracts with healthcare providers for continuous, value-based careall for a flat raterather than a negotiated fee for a particular service.

But Diamandis is right to bet on artificial intelligence in some regards;it is already predicting the onset of disease with some success. Whats unclear is how far forward these predictions can reach and how meaningful big data is to understanding how our bodies work. For example, while it may seem clever to sequence the genome of every new child born, one of Diamandiss ideas, it actually isnt as effective as a blood test for catching certain disorders, reporting has shown. Furthermore, the promise of predictive medicine may rest on a flawed assumption.

In a recent paper, Henrik Vogt, a post-doctoral fellow at the University of Oslo Center for Medical Ethics, lays out why big data may not deliver in the way Diamandis suggests. He says that as technology gets better at spotting indications of illness or the prospect of sickness in the body, it will surface more and more signals. But a predisposition for a disease does not equal a diagnosis. The main problem for big data screening is that monitoring many features of the body with highly sensitive technologies is bound to detect many abnormalities but without the ability to tell which, if any, will become clinically manifest. As a result, more people may be labeled with more harmless conditions, he writes.

We have to accept that there will always be some degree of risk, morbidity, and mortality.

Even if a person has a high likelihood for a disease, they may never present symptoms, Vogt notes. As more services and devicessuch as direct-to-consumer gene sequencing and wearables with heart rate variation detectionget more sophisticated, there is more visibility into a persons body. But there is also a lot of noise in this information. Not every little genetic abnormality may be meaningful. Different bodies may have different idiosyncrasies. While there is more room for prevention as we are all more aware of our disease risk, Vogt makes the case that there is also a risk of overtreatment, which could be costly and may also cause patients harm. Vogt also explained via email that there might be issues in investing too much in big data rather than another approach, such as social or institutional change.

That is not to say there isnt a huge opportunity to mitigate disease through data and intelligence, Vogt writes, but doctors need to rethink risk. We have to accept that there will always be some degree of risk, morbidity, and mortality, Vogt writes.

That perspective flies in the face of precision medicine, which tends to assumes the human body is like a machine, Vogt explains over email, something that can be measured, analyzed, and ultimately controlled. The historian Yuval Harari, for example, rather uncritically built his book Homo Deus on this assumption: that organism is algorithm,' he says. But human bodies dont work like that; they are unique in composition and environmental circumstance.Both for biological and statistical reasons, there are limits to how precisely and accurately the trajectory of a human life can be predicted. This obviously limits the promise of predictive medicine.

This point of view is crucial, because it is at the heart of some of the skepticism surrounding a big data-focused approach to medicine. It is the reason thatApple has doctors on staffto advise on the development of its medically minded hardware. For big data to really drive better health outcomes, as Vogt points out, there will have to be standards about what information is actionable and what is not.

Diamandis seems to concede that big data is not everything, Ultimately whats best is human and AI collaboratively, he says. But I thinkfor reading x-rays, MRIs, CT scans, genome data, and so forth, that once we put human ego aside, machine learning is a much better way to do that.

See the article here:
Amazon and Apple will be our doctors in the future, says tech guru Peter Diamandis - Fast Company

Read More...

The Outer Line: The impact of endurance training on the cardiac health of women – VeloNews

December 11th, 2019 10:44 am

Female cyclists are at a lower risk of suffering Sudden Cardiac Death than male athletes, but women should still learn about ways to screen for heart problems before engaging in endurance sports.

Dr. Mehreen Quhreshi is a cardiologist with advanced training in stress testing and cardiac imaging from Columbia University Medical Center in New York. She practices in Harrisburg, Pennsylvania and serves as the director of the Preventative Cardiology Program and the Nuclear Stress Lab at UPMC Pinnacle Heart and Vascular Institute. Dr. Bill Apollo, an amateur bike racer, runner, and duathlete is a Harrisburg, Pennsylvania-based cardiologist, who directs the UPMC Pinnacle Sports and Exercise Cardiology Clinic.

At the Paris Olympics in 1900, endurance sports were exclusively dominated by men; a mere 22 women participated, competing in the five gentrified events of croquet, equestrian, golf, tennis, and sailing. It took until the latter half of the twentieth century for the world to witness women competing in major Olympic endurance sports such as cycling (Los Angeles, 1984) and triathlon (Sydney, 2000).

Wider womens participation in the Olympics roughly coincided with the establishment of Title IX of the United States Educational Amendments of 1972, which mandated equal access for women in any program that received Federal funding including sports in public schools and universities. These two major developments fueled an explosion of female participation in a variety of events at all skill levels. The percentage of women finishers in marathons in the U.S. rose from only 10% in 1980 to a robust 45% by 2015. Women set a new record for Olympic participation at the 2016 Rio Olympics, with nearly equal numbers (5,176 athletes, or 45% of total), and with representation in all events included in the games.

Paradoxically, women have generally been under-represented in medical research studies looking at cardiac health, adaptation to endurance training and its potential consequences. Despite this surge of female athletic participation, we still havent achieved gender equality when it comes to understanding and caring for the female athletes heart. And recent small-scale studies suggest that there are in fact important cardiac differences between the sexes.

Some of the key questions are: to what extent do underlying genetic and hormonal factors impact normal changes in a womans heart related to exercise? How do these influences alter her risk for developing chronic heart problems or sudden cardiac death during competition? Are women better equipped to handle endurance training by design? Some recent research suggests that pregnancy subjects the female body to cardiac stresses similar to those that male athletes experience in even the most competitive events, including events like the Tour de France.

Below we examine the current understanding of cardiac development and risks in women endurance athletes, how and why women may differ from men in this regard, and recommended precautions that should be taken in training and competition by elite female endurance athletes.

Sudden cardiac death (SCD) during athletic competition is fortunately a rare occurrence, and it tends to affect men more commonly than women. In fact, a womans risk of SCD during endurance sports is estimated to be some 10 times lower than for her male colleagues. Professional cycling, during the past 3 seasons, has seen a total of 6 elite men tragically die directly from heart problems during races (5 in road racing, 1 on the track), with the most recent being Robbert de Greef in March 2019. During the same time period, there were zero incidents involving women, and indeed there are no known reports of SCD during elite womens cycling events for the past 20 years. Professional female cyclists are far more likely to die from training accidents (usually involving automobile collisions) than from heart problems.

Interestingly, these observations regarding SCD in cycling seem not to be true for other endurance sports. Marathon running has a huge participant base much larger than the womens pro peloton with nearly a half million participants in 2019 alone. This huge statistical sampling clarifies the measure of SCD risk: 1 incident per 150,000 participants overall, but more commonly occurring in men (1/ 100,000), and much less likely to occur in women (1/243,000).

Despite this fairly low risk of SCD in women, the sheer volume of running participants makes it easier to find reports of SCD. For example, Taylor Ceepo, age 22, died in May 2019 less than 1 mile from the finish line at the Rite-Aid Cleveland Marathon. The medical examiners report indicated that Ceepo experienced sudden cardiac death in association with physical exertion, pseudoephedrine use (a fairly benign over-the-counter decongestant) and cardiomyopathy. Her tragedy should remind us that even in very young and apparently healthy women, undiagnosed heart disease is still a common killer (3rd behind unintentional injuries and cancer in her age group), and her autopsy findings highlight the importance of screening women for underlying heart problems.

The most common causes of SCD are generally driven by age rather than sex. Athletes under age 35 both men and women alike are susceptible to genetically inherited structural heart problems including hypertrophic cardiomyopathy (HCM) and arrhythmogenic right ventricular cardiomyopathy (ARVC), as well as potentially lethal heart rhythm problems called channelopathies. Above age 35, coronary artery disease predominates, with women being preferentially protected by their higher estrogen levels, until they reach menopause. Initially, the ten-fold higher incidence of SCD in men was thought to be simply due to the much larger numbers of men participating in endurance sports. But now that participation rates are becoming nearly equal, womens risk of SCD is still not as high as that experienced in the male population.

Several theories exist that might explain why women appear to be more protected from SCD during intense competition. One explanation may lie in the sympathetic nervous system, which is responsible for the bodys fight or flight response. Male physiology is observed to be wound more tightly, meaning that their arteries and blood vessels tend to constrict more during intense activity than women. The increased blood pressure adds resistance to blood the heart is pumping out. When this increased pressure load is coupled with an outpouring of adrenaline during competition, the strains placed on the heart may trigger lethal rhythm problems in susceptible individuals generally those with underlying inherited cardiac problems or acquired fibrosis (scarring) from long-term training. For unclear reasons, even in the context of equal training volumes, men more commonly develop potentially lethal fibrosis substrate, placing them at higher risk of SCD than women.

Another possible explanation relates to obvious hormonal differences between men and women. In some animal models, testosterone has been shown to affect the way the heart conducts impulses making men, at least in theory more susceptible than women to developing electrical instability resulting in malignant heart arrhythmias. Clinically, testosterone promotes thickening of the heart muscle, which may explain why men are more susceptible than women in developing complications from diseases like HCM and ARVC. Estrogens, on the other hand, are protective in this regard, and delay that same process of heart muscle thickening. Despite equal patterns of genetic transmission of HCM and ARVC between both sexes, hormonal differences may explain why these maladies tend to remain latent for a longer period of time in women, presumably translating to a survival advantage and lower risk of SCD.

Sports medicine screening programs are designed to identify potential cardiac risks in individuals who exhibit no outward symptoms of heart problems. Such programs aim to increase participation but to do so with a reasonable level of caution, to ensure the safety of the athlete. Despite the lower risk of SCD in women, screening is still important.

Pre-participation screening typically involves a comprehensive medical history review, focused physical examination, and in some cases an electrocardiogram (EKG). EKG tests are proven to be more sensitive than history and physical examination alone in detecting pathology, especially regarding heart rhythm issues. EKG interpretation should always be completed by a skilled reader able to distinguish the fine line between normal adaptation to exercise and pathology. Guidelines like the International Recommendations for EKG Interpretation in Athletes will increase reading accuracy and reduce the number of false findings, which often lead to expensive and unnecessary longitudinal testing. Men exhibit changes in their EKG patterns more often than women, and these variations in many instances are considered normal purely as the result of physiologic adaptation to training. On the other hand, women are less likely to stray from normal parameters, so most EKG changes are concerning and more likely represent a real problem.

Consistent endurance training induces physiologic remodeling, or normal adaptations to the heart resulting in improved efficiency of an athletes engine. Cyclists are unique because they typically perform the most prolonged exercise pattern more hours per day and more days per year than nearly any other athletes. Cyclists often sustain markedly elevated heart rates for extended periods of time during two distinct types of high cardiac output workouts. First, high intensity aerobic workouts at near peak efficiency, coupled with sustained elevations in heart rate, create a dynamic stress, or a volume load on the heart. And second, long tempo efforts punctuated by intense anaerobic dashes create static stress, exposing the heart to a pressure load because of sustained increases in blood pressure.

Cyclists therefore typically exhibit prominent changes in heart structure due to a combination of dynamic stress (volume overload) and static stress (pressure overload) resulting in generally increased cardiac mass, with mildly enlarged hearts and mildly increased heart wall thickness at least in men. Statistically, women are generally smaller than men with lower lean body mass. Due to their higher estrogen levels, women tend to adapt to exercise in a qualitatively similar manner, but quantitatively different than men showing only minimal heart enlargement and virtually no heart wall thickening. In fact, only about 7% of healthy women show any significant increase in their heart size due to habitual exercise, whereas 47% of men show cardiac enlargement.

Symptoms of heart problems in women are often different to those reported by men. For example, women are less likely to experience classic chest pain due to a heart problem, but may report more subtle symptoms like indigestion, heartburn, fatigue, or poor exercise performance. Misinterpretation of these sometimes confusing symptoms often leads to a delay in diagnosis and poorer long-term outcomes for women. An unexplained decline in athletic performance is obviously concerning to any elite athlete whether male or female because this may be the only clue to a serious underlying heart problem.

However, in young women, such nonspecific symptoms are often incorrectly blamed on things like menstrual problems, eating disorders, iron deficiency anemia, pregnancy, or thyroid disease. In many cases it is the womans primary care provider who must be savvy enough to exclude these other diagnoses, realizing there is a potential heart problem and then making an appropriate referral to a cardiologist.

Estrogen generally protects women from developing CAD at young ages, but the risk rises as they reach menopause. And paradoxically, some young women may actually be at increased risk for CAD because of a syndrome called Relative Energy Deficiency in Sports (RED-S). Sports which favor lean body mass are often associated with heavy training loads and dieting to achieve optimal body weight. In some women this results in the Female Athlete Triad of menstrual dysfunction, unexplained decline in performance (with or without an eating disorder), and decreased bone density, leading to increased probability of fractures.

Prolonged endurance training in young women can lead to menstrual irregularities resulting in the same kind of reduced estrogen levels typically seen in older postmenopausal women. These athletes should be evaluated for the more traditional cardiac risk factors such as high blood pressure, cholesterol problems, and diabetes, with appropriate intervention to modify their risk. Treatment of the Female Athlete Triad is challenging and may require a multidisciplinary approach to improve an athletes overall energy balance. Strategies include decreasing training volume, modifying dietary habits, medically replacing estrogen levels, promoting bone health with dietary supplements, and seeking appropriate professional help to correct eating disorders if present. Due to the focused and highly competitive nature of many endurance athletes, this is often a tall order to fill since they may resist decreasing their training volume.

Regular exercise is the cornerstone of prevention and treatment of many cardiac and non-cardiac diseases. But some researchers suggest that the benefits of exercise are like a drug the benefits of moderate training reach a plateau and exceeding that plateau, or overdosing, may be detrimental to the athletes health. Several studies have reported unexpected abnormalities in endurance athletes primarily in men suggesting either transient or permanent heart damage which puts them at risk for chronic heart issues. Findings have included a five-fold increased risk of atrial fibrillation (AFIB), increased coronary artery calcium deposits (which indicate clinically silent CAD), and scarring of the heart muscle. However, there are several general guidelines that all athletes should be aware of:

The biological adaptation to handle the stress of pregnancy may be a key reason for the apparently better female adaptation to endurance training. Recent research has highlighted that during pregnancy, the body functions at a basal metabolic rate of 2.2 times the normal burning up to 4000 calories a day. Extended over a period of 40 weeks, pregnancy can essentially be considered the ultimate endurance event a true test on the limits of human performance. Under typical circumstances, a body functioning above 2.5 times the normal metabolic rate over a prolonged period will begin to break down. But most women emerge from pregnancy and go on to live healthy lives, having tolerated a level of metabolic strain considered by some to be similar to that experienced by athletes participating in some of the most competitive endurance events.

There are also massive changes in the amount of fluid in a womans body during pregnancy, creating cardiac stresses similar to endurance training. In order to support the developing fetus, she must increase her blood volume by a massive 50%, and her cardiac output by 40-50% constituting the ultimate dynamic stress on the heart. The female body appears to require less adaptation by the heart muscle and chambers to accommodate these changes.

More overlap in research examining the similarities between the effects of endurance training in women and the cardiac demands placed on them during pregnancy may help to explain these gender-based differences in adaptation to exercise and related cardiac risk. Additional research specifically devoted to women is critical to a better understanding of how gender influences normal cardiac adaptation to exercise, as well as to more accurately identify pathologic conditions which sometimes seem to overlap with normal physiology.

Despite the substantially lower risk of SCD in women, cardiac risk screening of female endurance athletes and at-risk pregnant women is still important, and should be carried out by clinicians familiar with the differences in adaptive physiology between men and women. Women often experience challenging and atypical cardiac symptoms, requiring a high index of suspicion on the part of their doctors often at the primary care level to identify these underlying problems. As the current generation of elite female athletes matures into tomorrows Masters champions, we will undoubtedly learn a great deal more about the long-term cardiac implications of endurance training in women.

Link:
The Outer Line: The impact of endurance training on the cardiac health of women - VeloNews

Read More...

MEET THE CANDIDATES: RICHARD QUIGLEY – Island Echo

December 11th, 2019 10:44 am

In the 5th of our interviews with the candidates seeking to become Member of Parliament for the Isle of Wight this Thursday, Island Echo gave Labour candidate, Richard Quigley, the opportunity to make the case for voting for a Labour MP to represent the Island.

Those who see lack of connectivity as the biggest issue facing Islanders have the opportunity to vote for the pro-fixed link independent, Carl Feeney. Islanders for whom the so-called climate emergency is the greatest concern have the option of voting for the Green candidate, Vix Lowthion. Leavers in favour of the hardest of hard Brexits can vote for the independent pro-Brexit candidate, Daryll Pitcher. And if your answer is none of the above, then you have the option to choose quirky independent, Karl Love.

However, for many voters, the issue of paramount importance is who will enter Downing Street and form a government on 13th December. Will it be Jeremy Corbyn and Labour or Boris Johnson and the Tories? Voters will also be deciding whether they want Boris Withdrawal Agreement implemented and get Brexit done, or would they prefer further negotiations and a second referendum under Labour?

Interview:

Richard Quigley grew up in Retford, Nottinghamshire, a coal mining area. He remembers the Miners Strike of 1982 from when he was growing up. Interestingly, his parents were Conservative councillors.

Richards political awakening began when he left school for university and joined the protests against the poll tax. Richard has been a member of the Labour Party for four years, having been inspired to join by the leadership of Jeremy Corbyn, Richard first moved to the Island in 2003. He is a small businessman in the catering trade, and owner of fish and chip shop, Corries Cabin, in Cowes. Richards father-in-law was a Cowes window cleaner, and it was he who suggested his son-in-law set up his business there.

Richard is married to Leah and they have two daughters, aged 17 and 12. Richard has also worked as a stand up comedian.

Small businesses have had their best years under Labour. Labour governments put money into the economy. All businesses need customers.

I joined because of Jeremy Corbyn. I find it inspirational to find someone who gets out of bed each morning to try and make this country a better place to live in. I dont think we can say the same about the Tories. I see the election as a battle between Corbyn and Johnson. It is an absolute privilege for me to be the parliamentary candidate and try to change whats going on.

I dont think Jeremy Corbyn is an anti-semite. He has spent the whole of his life fighting racism and prejudice. There is no place for anti-semitism in society. Of course, when you uncover anti-semitism in order to deal with it, this draws attention to the problem. But uncovering it is the right thing to do. I have never come across anti-semitism on the Island and would never accept racism in my friendship group.

There is no evidence that Jeremy Corbyn ever supported the IRA. If he was a supporter of terrorism, then MI5 would have uncovered this. Jeremy Corbyn is (using the words of Winston Churchill) in favour of jaw-jaw rather than war-war.

We would end austerity in our first term. We would invest for return in both council houses and people. We would transform the NHS from being a National Sickness Service to an organisation that invests in preventative medicine.

Tories believe that everything is static, that the economy is a zero-sum game. But when you go to a bank to ask for a loan, you create money. You dont have to travel to the moon to dig it up. Are you in favour of a fixed link? Im 50/50 on this issue. I totally see the economic and social benefits of a fixed link. I also see the drawbacks.

We need a properly funded feasibility study, followed by an all-Island referendum on the issue.

I voted to remain. Im one of the 48 per cent. Ive been a European citizen for 48 years of my life. Those who voted for leave are not stupid. The problem is that there is no clarity as to which version of Brexit needs to be implemented. We need to find the optimal version of Brexit and then put it to the people. I agree with Jeremy Corbyns stance of neutrality on the issue.

I fully understand Working Class voters being upset with the idea of their win being taken away from them. But they are the people who would be most harmed by a no deal Brexit.

I get out of bed every morning believing we can do it. 8 or 9 years ago, Labour was a wasted vote on the Island. However, we doubled our vote share in 2017. There are 30,000 Islanders who dont turn out to vote. We have a great team running a great campaign. Were on the road to success. I just hope success comes this time round.

There were some big majorities overturned in the 2017 General Election. Just look at Kensington, the wealthiest constituency in the country.

Because I genuinely care about Islanders and the Island. Im passionate about opportunities for young people and rebuilding communities. I dont need to do this as a career. I would be happy just to sit on the backbenches and represent Islanders.

The big thing for me, when looking at the country and the Island, is that many people are not happy with what they see and the way the party they usually vote for is behaving.

Some of you may not have considered voting before. Lend me your vote on Thursday and judge me on what we achieve.

If we can spend 550 billion pounds to bale out the banks (9,000 pounds for every man, woman and child in the country) then surely we can afford a hundred quid a head to help save the NHS.

Having given a platform to all candidates standing for election in the Isle of Wight constituency, tomorrow (Wednesday) Island Echo will publish an in-depth interview with the odds-on favouriteand sitting MP, Bob Seely (Conservative).

See more here:
MEET THE CANDIDATES: RICHARD QUIGLEY - Island Echo

Read More...

OH needs to work more with other professions on wellbeing strategies, says SOM – Personnel Today

December 11th, 2019 10:44 am

Shutterstock

Occupational health professionals should get more involved in the provision of wellbeing services and need to work more with other professional groups to improve health outcomes, according to SOM, the Society of Occupational Medicine.

In a new report, The value of occupational health to workplace wellbeing, SOM argued that OH practitioners knowledge, skills and competencies can add significant value to organisations wellbeing programmes.

But OH will need to collaborate and work more with other professionals such as HR or diversity and inclusion specialists, rather than in silos, for wellbeing provision to be successful.

This was for two reasons, the report said. Firstly, some programmes might be tied to wider employer initiatives such as job redesign, flexible working, employee benefits, diversity and inclusion and cultural transformation. Secondly, the benefits of wellbeing programmes might not be seen explicitly in health outcomes, for example through employee engagement or staff retention.

A survey of 62 SOM members found that 84% offered workplace wellbeing programmes as a preventative measure to improve the health of staff; 50% introduced them to support other metrics, such as reducing sickness absence; and 45% thought they would improve productivity.

Two-thirds (66%) said their HR department was responsible for wellbeing activities, 60% said OH had some responsibility in this area and 40% said they had appointed a wellbeing manager or similar position to oversee the development and deployment of wellbeing programmes.

Mindfulness and mental wellbeing activities formed part of 84% of SOM members wellbeing programmes. Half said their programme included activity/exercise and 45% identified management training as a core component in their wellbeing offer.

SOMs report identifies four major areas of knowledge, skills and competencies required by OH practitioners to implement workplace health and wellbeing programmes. These were: building the business case for health and wellbeing; acquiring and using evidence; knowledge of health and wellbeing; and building and sustaining a programme of activities.

The report concluded: It is clear from the available evidence that in addition to technical and functional knowledge of health conditions and the ability to appraise evidence critically, occupational health practitioners can add value to workplace health and wellbeing programmes by acquiring and using skills related to change management processes.

Specific challenges in developing such skills across the occupational health professions may relate to adding new material into what may be already crowded curricula in academic and professional qualifications.

View original post here:
OH needs to work more with other professions on wellbeing strategies, says SOM - Personnel Today

Read More...

Lineage Cell Therapeutics and AgeX Therapeutics Announce Issuance of US Patent for Method of Generating Induced Pluripotent Stem Cells – BioSpace

December 11th, 2019 10:43 am

The issuance of this patent highlights Lineages dominant position in the field of cell therapy, stated Brian M. Culley, CEO of Lineage. Our efforts to develop new treatments rely on well-characterized and NIH-approved human cell lines. These lines are not genetically manipulated, which avoids the safety concerns associated with genetic aberrations arising from the creation of iPS cells. We believe the Lineage cell lines provide the safest option for our current clinical-stage programs, particularly in immune-privileged anatomical sites such as the eye (OpRegen for the treatment of dry AMD) and spinal cord (OPC1, for the treatment of spinal cord injury). However, the vast intellectual property estate which underlies our cell therapy platform has never been limited to these particular cell lines. As one example, this newly-issued patent provides us with proprietary methods for producing induced pluripotent stem cells, or, as it was practiced by us prior to Yamanaka, Analytical Reprogramming Technology (ART). In certain settings, an ART/iPS approach might offer important advantages, such as for an autologous treatment or when the selection of preferential attributes from a series of iPS lines is desirable. Questions as to which stem cell technology is preferred ultimately will be answered by clinical safety and efficacy and likely will be indication-specific, so we believe it is in the best interest of our shareholders to generate patented technology which enables us to pursue programs in either or both formats which we believe will ensure the highest probability of success.

This patent broadly describes multiple techniques for reprogramming cells of the body back to the all-powerful stem cell state, said Dr. Michael D. West, CEO of AgeX and first inventor on the patent. Perhaps more significantly, it includes certain factors that address some of the difficulties currently encountered with iPS cells. It also reflects the foundational work our scientists have undertaken to apply reprogramming technology to age-reversal, specifically, induced Tissue Regeneration (iTR) which is currently a focus of AgeX product development.

Induced Pluripotent Stem Cells (iPS) are typically derived from adult skin or blood cells which have been reprogrammed or induced to retrace their developmental age and regain the potential to form all of the young cell and tissue types of the body. In 2010 inventors of the -723 patent issued today demonstrated that this reversal of developmental aging even extended to the telomere clock of cell aging. This reprogramming technology provides an alternate source of starting material for the manufacture of potentially any type of human cell needed for therapeutic purposes. Because iPSCs can be derived directly from adult tissues, they can be used to generate pluripotent cells from patients with known genetic abnormalities for drug discovery or as an alternative source of cell types for regenerative therapies.

U.S. Patent No. 10,501,723, entitled Methods of Reprogramming Animal Somatic Cells was assigned to Advanced Cell Technology of Marlborough, Massachusetts (now Astellas Institute for Regenerative Medicine) and licensed to Lineage and sublicensed to AgeX Therapeutics for defined fields of use. Inventors of the patent include Michael D. West, CEO of AgeX and previous CEO of Advanced Cell Technology, Karen B. Chapman, Ph.D., and Roy Geoffrey Sargent, Ph.D.

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineages programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineages clinical assets include (i) OpRegen, a retinal pigment epithelium transplant therapy in Phase I/IIa development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase I/IIa development for the treatment of acute spinal cord injuries; and (iii) VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells currently in Phase I development for the treatment of non-small cell lung cancer. Lineage is also evaluating potential partnership opportunities for Renevia, a facial aesthetics product that was recently granted a Conformit Europenne (CE) Mark. For more information, please visit http://www.lineagecell.com or follow the Company on Twitter @LineageCell.

About AgeX Therapeutics

AgeX Therapeutics, Inc. (NYSE American: AGE) is focused on developing and commercializing innovative therapeutics for human aging. Its PureStem and UniverCyte manufacturing and immunotolerance technologies are designed to work together to generate highly-defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a variety of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeXs revolutionary longevity platform induced Tissue Regeneration (iTR) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues. AGEX-iTR1547 is an iTR-based formulation in preclinical development. HyStem is AgeXs delivery technology to stably engraft PureStem cell therapies in the body. AgeX is developing its core product pipeline for use in the clinic to extend human healthspan and is seeking opportunities to establish licensing and collaboration agreements around its broad IP estate and proprietary technology platforms. For more information, please visit http://www.agexinc.com or connect with the company on Twitter, LinkedIn, Facebook, and YouTube.

Forward-Looking Statements

Lineage cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as believe, may, will, estimate, continue, anticipate, design, intend, expect, could, plan, potential, predict, seek, should, would, contemplate, project, target, tend to, or the negative version of these words and similar expressions. Such statements include, but are not limited to, Lineages exploration of alternative cell therapy platforms. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Lineages actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including risks and uncertainties inherent in Lineages business and other risks in Lineages filings with the Securities and Exchange Commission (the SEC). Lineages forward-looking statements are based upon its current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. Further information regarding these and other risks is included under the heading Risk Factors in Lineages periodic reports with the SEC, including Lineages Annual Report on Form 10-K filed with the SEC on March 14, 2019 and its other reports, which are available from the SECs website. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191210005404/en/

Original post:
Lineage Cell Therapeutics and AgeX Therapeutics Announce Issuance of US Patent for Method of Generating Induced Pluripotent Stem Cells - BioSpace

Read More...

Magenta Therapeutics Demonstrates First-ever Successful Gene Therapy Transplant Without Chemotherapy in Primates Using a Single Dose of Antibody-drug…

December 11th, 2019 10:43 am

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced that new results from its CD117-ADC patient preparation program were presented at the 61st Annual Meeting of the American Society of Hematology (ASH). These results, which were highlighted in an oral presentation at ASH by John Tisdale, M.D., Director, Molecular and Clinical Hematology Section, National Institutes of Health, showed the first-ever successful transplant of gene-modified cells in non-human primates using a targeted, single-agent antibody-drug conjugate (ADC), without the use of chemotherapy or radiation.

Todays conditioning regimens involve high doses of chemotherapy, often paired with radiation, to remove the disease-causing cells. As a result, patients undergoing gene therapy or stem cell transplant are all faced with a difficult choice: whether to endure severe toxicity and risk infertility and cancer for the chance for a cure. Magentas portfolio of targeted ADCs represents an extremely promising new option to prepare patients for gene therapy or transplant with no need for toxic chemotherapy or radiation, said Dr. Tisdale. The results presented today show that a single dose of single agent CD117-ADC achieves the same level of depletion as four doses of busulfan chemotherapy to enable successful engraftment and persistence of stem cells modified with the -globin gene, the gene that causes sickle cell disease and -thalassemia when mutated. Importantly, the animals undergoing preparation with CD117-ADC showed none of the damaging toxicities associated with busulfan conditioning.

Magenta is the only company with the people, platforms and a product engine committed to comprehensively transforming immune and blood system reset, which includes revolutionizing the toxic methods that are used to prepare patients for gene therapy and transplant today. said Jason Gardner, D.Phil., Chief Executive Officer and President, Magenta Therapeutics. The gene therapy field has learned that higher levels of stem cell depletion, which meant higher doses of busulfan, were needed to ensure long-term engraftment of the gene-modified cells and persistence of gene therapy. Across all the modalities we have tested, we have seen that ADCs are most effective at achieving these high levels of stem cell depletion without chemotherapy to enable engraftment and long-term durability of the transplant. Todays impressive results provide important validation of the ADC approach as well as the CD117 target for patient preparation and underscore Magentas leadership in the field of conditioning.

Results from the CD117-ADC Patient Preparation Program

Title: A Single Dose of CD117 Antibody Drug Conjugate Enables Autologous Gene-Modified Hematopoietic Stem Cell Transplant (Gene Therapy) in Nonhuman Primates (Abstract #610)Presenter: John Tisdale, M.D., Director, Molecular and Clinical Hematology Section, National Institutes of Health, Bethesda, Md.

Magentas most advanced patient preparation program, CD117-ADC, targets CD117, a protein expressed on hematopoietic stem cells. CD117-ADC is designed to remove the genetically mutated cells in the bone marrow that cause certain genetic diseases, such as sickle cell disease, enabling curative stem cell transplant or gene therapy.

Results presented by Dr. Tisdale showed:

About Magenta Therapeutics

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with autoimmune diseases, genetic diseases and blood cancers. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant world to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Mass. For more information, please visit http://www.magentatx.com.

Follow Magenta on Twitter: @magentatx.

Forward-Looking Statement

This press release may contain forward-looking statements and information within the meaning of The Private Securities Litigation Reform Act of 1995 and other federal securities laws. The use of words such as may, will, could, should, expects, intends, plans, anticipates, believes, estimates, predicts, projects, seeks, endeavor, potential, continue or the negative of such words or other similar expressions can be used to identify forward-looking statements. The express or implied forward-looking statements included in this press release are only predictions and are subject to a number of risks, uncertainties and assumptions, including, without limitation risks set forth under the caption Risk Factors in Magentas Registration Statement on Form S-1, as updated by Magentas most recent Quarterly Report on Form 10-Q and its other filings with the Securities and Exchange Commission. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although Magenta believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, except as required by law, neither Magenta nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements included in this press release. Any forward-looking statement included in this press release speaks only as of the date on which it was made. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

The rest is here:
Magenta Therapeutics Demonstrates First-ever Successful Gene Therapy Transplant Without Chemotherapy in Primates Using a Single Dose of Antibody-drug...

Read More...

Why Sangamo Therapeutics Stock Sank Today – The Motley Fool

December 11th, 2019 10:43 am

What happened

Shares of Sangamo Therapeutics (NASDAQ:SGMO) were sinking 11.7% lower as of 3:28 p.m. EST on Tuesday. This marked the second consecutive day of double-digit-percentage declines for the biotech stock after Sangamo announced preliminary results on Monday from a phase 1/2 clinical study evaluating experimental gene-editing therapy ST-400 in treating rare blood disease transfusion-dependent beta thalassemia (TDT).

Those preliminary results were for the first three patients in Sangamo's Thales clinical trial targeting beta thalassemia. The good news was that all three patients receiving ST-400 quickly experienced reconstitution of their hematopoietic stem cells after gene editing as well as demonstrating neutrophil engraftment -- the first day where the patients' neutrophil counts were at least 500 cells per microliter for three consecutive days.

Image source: Getty Images.

The not-so-good news related to the adverse effects experienced by the patients. One patient experienced a serious adverse event with hypersensitivity during the ST-400 infusion, although the issue resolved by the end of the infusion. Also, another patient's fetal hemoglobin levels increased by less than 1 gram per deciliter through week 26 of the study. The goal of ST-400 is to boost fetal hemoglobin levels enough to minimize the negative effects of beta thalassemia.

University of Minnesota Associate Professor Angela Smith, a principal investigator of the Thales study, noted that "the full effects of the treatment may take as long as 12 to 18 months or more to manifest." She added, "Longer-term follow-up, including from additional patients, will be necessary to understand the safety profile and potential clinical benefit of ST-400 in beta-thalassemia."

Adrian Woolfson, Sangamo's head of research and development, stated, "Our understanding of ST-400 will continue to evolve as we follow the progress of these and additional patients in the coming year, and those dosed in Sanofi's BIVV003 clinical trial, which is evaluating the same gene-editing approach in sickle cell disease."

This cautious language from both Smith and Woolfson underscores the tentative nature of the preliminary results.

Investors will have to wait a while to learn just how much promise ST-400 holds. Sangamo expects to announce additional study results late next year after enrollment in the Thales study is completed and after all six patients in the study have been observed for longer periods.

Sangamo's last week or so has demonstrated the volatility associated with biotech stocks, especially those with no approved drugs on the market. Sangamo jumped last week on positive results from another study (of hemophilia gene therapy SB-525) but gave up those gains and then some on the news for ST-400.

Continued here:
Why Sangamo Therapeutics Stock Sank Today - The Motley Fool

Read More...

Page 799«..1020..798799800801..810820..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick